645 related articles for article (PubMed ID: 33112399)
1. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399
[TBL] [Abstract][Full Text] [Related]
2. The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE.
Goto S; Turpie AGG; Farjat AE; Weitz JI; Haas S; Ageno W; Goldhaber SZ; Angchaisuksiri P; Kayani G; MacCallum P; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
Thromb Res; 2021 Jul; 203():155-162. PubMed ID: 34023735
[TBL] [Abstract][Full Text] [Related]
3. Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
Chen AC; Rao AS; Oropallo A; Goldhaber SZ; Fluharty ME; Maheshwari U; Carrier M; Turpie AGG; Pieper K; Kayani G; Kakkar AK;
Thromb Res; 2023 Dec; 232():123-132. PubMed ID: 37976732
[TBL] [Abstract][Full Text] [Related]
4. Measures of Kidney Disease and the Risk of Venous Thromboembolism in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.
Cheung KL; Zakai NA; Folsom AR; Kurella Tamura M; Peralta CA; Judd SE; Callas PW; Cushman M
Am J Kidney Dis; 2017 Aug; 70(2):182-190. PubMed ID: 28126238
[TBL] [Abstract][Full Text] [Related]
5. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
6. Venous Thromboembolism and Renal Impairment: Insights from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D; Sebastian T; Banyai M; Beer JH; Mazzolai L; Baldi T; Aujesky D; Hayoz D; Engelberger RP; Kaeslin T; Korte W; Escher R; Husmann M; Mollet A; Szucs TD; Kucher N
Semin Thromb Hemost; 2019 Nov; 45(8):851-858. PubMed ID: 31622993
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism.
Fang MC; Reynolds K; Fan D; Prasad PA; Sung SH; Portugal C; Garcia E; Go AS
JAMA Netw Open; 2023 Aug; 6(8):e2328033. PubMed ID: 37581888
[TBL] [Abstract][Full Text] [Related]
8. Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry.
Goto S; Angchaisuksiri P; Bassand JP; Camm AJ; Dominguez H; Illingworth L; Gibbs H; Goldhaber SZ; Goto S; Jing ZC; Haas S; Kayani G; Koretsune Y; Lim TW; Oh S; Sawhney JPS; Turpie AGG; van Eickels M; Verheugt FWA; Kakkar AK;
J Am Heart Assoc; 2019 Feb; 8(3):e010510. PubMed ID: 30717616
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease in patients with cancer and its association with occurrence of venous thromboembolism and mortality.
Königsbrügge O; Lötsch F; Zielinski C; Pabinger I; Ay C
Thromb Res; 2014 Jul; 134(1):44-9. PubMed ID: 24792954
[TBL] [Abstract][Full Text] [Related]
10. Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and design.
Weitz JI; Haas S; Ageno W; Angchaisuksiri P; Bounameaux H; Nielsen JD; Goldhaber SZ; Goto S; Kayani G; Mantovani L; Prandoni P; Schellong S; Turpie AG; Kakkar AK
Thromb Haemost; 2016 Nov; 116(6):1172-1179. PubMed ID: 27656711
[TBL] [Abstract][Full Text] [Related]
11. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.
Turpie AGG; Farjat AE; Haas S; Ageno W; Weitz JI; Goldhaber SZ; Goto S; Angchaisuksiri P; Kayani G; Lopes RD; Chiang CE; Gibbs H; Tse E; Verhamme P; Ten Cate H; Muntaner J; Schellong S; Bounameaux H; Prandoni P; Maheshwari U; Kakkar AK;
Thromb Res; 2023 Feb; 222():31-39. PubMed ID: 36565677
[TBL] [Abstract][Full Text] [Related]
12. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
Weitz JI; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
J Thromb Thrombolysis; 2020 Aug; 50(2):267-277. PubMed ID: 32583306
[TBL] [Abstract][Full Text] [Related]
13. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
14. Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer-associated venous thromboembolism during anticoagulant treatment.
Kooiman J; den Exter PL; Cannegieter SC; le Cessie S; del Toro J; Sahuquillo JC; Pedrajas JM; Huisman MV
J Thromb Haemost; 2013 Nov; 11(11):1968-76. PubMed ID: 24112123
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study.
Cheung KL; Zakai NA; Callas PW; Howard G; Mahmoodi BK; Peralta CA; Judd SE; Kurella Tamura M; Cushman M
J Thromb Haemost; 2018 Sep; 16(9):1743-1752. PubMed ID: 29984467
[TBL] [Abstract][Full Text] [Related]
16. Influence of baseline anemia on long-term clinical outcomes in patients with venous thromboembolism: from the COMMAND VTE registry.
Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
J Thromb Thrombolysis; 2019 Apr; 47(3):444-453. PubMed ID: 30673941
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease is associated with increased risk of venous thromboembolism recurrence.
Rattazzi M; Villalta S; De Lucchi L; Sponchiado A; Galliazzo S; Faggin E; Pagliara V; Zilli C; Callegari E; Caberlotto L; Puato M; Pauletto P
Thromb Res; 2017 Dec; 160():32-37. PubMed ID: 29091810
[TBL] [Abstract][Full Text] [Related]
18. Influence of Baseline Platelet Count on Outcomes in Patients With Venous Thromboembolism (from the COMMAND VTE Registry).
Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Watanabe H; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
Am J Cardiol; 2018 Dec; 122(12):2131-2141. PubMed ID: 30293653
[TBL] [Abstract][Full Text] [Related]
19. Direct Oral Anticoagulant Use in Chronic Kidney Disease and Dialysis Patients With Venous Thromboembolism: A Systematic Review of Thrombosis and Bleeding Outcomes.
Cheung CYS; Parikh J; Farrell A; Lefebvre M; Summa-Sorgini C; Battistella M
Ann Pharmacother; 2021 Jun; 55(6):711-722. PubMed ID: 33073581
[TBL] [Abstract][Full Text] [Related]
20. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
